List of Tables
Summary Table : Global Market for AI Medical Diagnostics, by Region, Through 2026
Table 1 : FDA-Cleared AI Radiology and Other Imaging Modalities in the U.S., 2018-2021
Table 2 : FDA-Approved AI Algorithms for Radiology and Medical Imaging in the U.S., 2018-2021
Table 3 : Global Leading Causes of Burden of Disease, 2004 and 2030
Table 4 : Cancer Statistics Across Major Asian Countries, by Cancer Site/Type, 2020
Table 5 : Global Market for AI Medical Diagnostics, by Component, Through 2026
Table 6 : Global Market for AI Software in Medical Diagnostics, by Region, Through 2026
Table 7 : Global Market for AI Services in Medical Diagnostics, by Region, Through 2026
Table 8 : Global Market for AI Hardware in Medical Diagnostics, by Region, Through 2026
Table 9 : Global Market for AI Medical Diagnostics, by Medical Specialty Application Area, Through 2026
Table 10 : Global Deaths from Cancer, 2015 and 2030
Table 11 : Global Market for AI Medical Diagnostics in Oncology, by Region, Through 2026
Table 12 : Recent Examples of Machine Learning in Cardiology
Table 13 : Global Deaths from CVD, 2015 and 2030
Table 14 : Global Market for AI Medical Diagnostics in Cardiology, by Region, Through 2026
Table 15 : Number of DALYs for Neurological Disorders and as Share of Global DALYs Projected for 2005 and 2030
Table 16 : Deaths Attributable to Neurological Disorders, 2005 and 2030
Table 17 : Global Market for AI Medical Diagnostics in Neurology, by Region, Through 2026
Table 18 : Global Percentage Distribution of Population Aged Above 65, by Region, 2015 and 2050
Table 19 : Global Market for AI Medical Diagnostics in Orthopedics, by Region, Through 2026
Table 20 : Global Market for AI Medical Diagnostics in Other Disease Treatments, by Region, Through 2026
Table 21 : Global Market for AI Medical Diagnostics, by End User, Through 2026
Table 22 : Number of Hospitals in the U.S., by Type, 2020
Table 23 : Global Market for AI in Hospitals and Clinics, by Region, Through 2026
Table 24 : Global Market for AI Medical Diagnostics in Diagnostic Imaging Centers and Diagnostic Laboratories, by Region, Through 2026
Table 25 : Global Market for AI Medical Diagnostics, by Modality, Through 2026
Table 26 : Global Market for AI-Based MRI Scans, by Region, Through 2026
Table 27 : Global Market for AI-Based CT Scans, by Region, Through 2026
Table 28 : Some Major Uses of Ultrasound
Table 29 : Global Market for AI-Based Ultrasound, by Region, Through 2026
Table 30 : Global Market for AI-Based X-Rays, by Region, Through 2026
Table 31 : Global Market for AI-Based Other Imaging Techniques, by Region, Through 2026
Table 32 : Global Market for AI Medical Diagnostics, by Region, Through 2026
Table 33 : North American Market for AI Medical Diagnostics, by Component, Through 2026
Table 34 : North American Market for AI Medical Diagnostics, by Medical Specialty Application Area, Through 2026
Table 35 : North American Market for AI Medical Diagnostics, by Modality, Through 2026
Table 36 : North American Market for AI Medical Diagnostics, by End User, Through 2026
Table 37 : North American Market for AI Medical Diagnostics, by Country, Through 2026
Table 38 : Top Funded AI Start-ups in the United States, 2021
Table 39 : Confirmed Cases of COVID-19 in Europe, by Country, as of December, 2021
Table 40 : European Market for AI Medical Diagnostics, by Component, Through 2026
Table 41 : European Market for AI Medical Diagnostics, by Medical Specialty Application Area, Through 2026
Table 42 : European Market for AI Medical Diagnostics, by Modality, Through 2026
Table 43 : European Market for AI Medical Diagnostics, by End User, Through 2026
Table 44 : European Market for AI Medical Diagnostics, by Country, Through 2026
Table 45 : Start-ups in the German Market for AI Medical Diagnostics
Table 46 : Start-ups in the French Market for AI Medical Diagnostics
Table 47 : Start-ups in the Spanish Market for AI Medical Diagnostics
Table 48 : Start-ups in the Rest of European Market for AI Medical Diagnostics
Table 49 : Asia-Pacific Market for AI Medical Diagnostics, by Component, Through 2026
Table 50 : Asia-Pacific Market for AI Medical Diagnostics, by Medical Specialty Application Area, Through 2026
Table 51 : Asia-Pacific Market for AI Medical Diagnostics, by Modality, Through 2026
Table 52 : Asia-Pacific Market for AI Medical Diagnostics, by End User, Through 2026
Table 53 : Asia-Pacific Market for AI Medical Diagnostics, by Countries, Through 2026
Table 54 : Japanese Market Statistics
Table 55 : Number of New Cancer Cases in Japan in Both Sexes, by All Age Groups, 2020
Table 56 : Funding of AI Diagnostics Start-ups in Rest of Asia-Pacific Countries
Table 57 : Rest of the World Market for AI Medical Diagnostics, by Component, Through 2026
Table 58 : Rest of the World Market for AI Medical Diagnostics, by Medical Specialty Application Area, Through 2026
Table 59 : Rest of the World Market for AI Medical Diagnostics, by Modality, Through 2026
Table 60 : Rest of the World Market for AI Medical Diagnostics, by End User, Through 2026
Table 61 : Regulation Pertaining AI Medical Diagnostics Across Countries
Table 62 : Siemens Healthcare GmbH Patents, 2019-2021
Table 63 : General Electric Co. Patents, 2019-2021
Table 64 : Patents Granted to Other Major Market Players, 2019-2021
Table 65 : Start-ups Founded in the AI Medical Diagnostics Industry, 2020-2021
Table 66 : Major Market Strategies in Global Market for AI Medical Diagnostics, 2018-2021
Table 67 : List of Partnerships, Collaborations, Agreements and Contracts, 2020-2021
Table 68 : List of FDA, CE Mark and EU Approvals, 2020 and 2021
Table 69 : Aidoc Medical Ltd.: Product Portfolio
Table 70 : Aidoc Medical Ltd.: Strategies and Development
Table 71 : Arterys Inc.: Product Portfolio
Table 72 : Arterys Inc.: Strategies and Development
Table 73 : Behold.ai: Product Portfolio
Table 74 : Behold.ai: Strategies and Development
Table 75 : Butterfly Network: Product Portfolio
Table 76 : Butterfly Network: Strategies and Development
Table 77 : Canon Medical: Company Financials, 2019 and 2020
Table 78 : Canon Medical System: Product Portfolio
Table 79 : Canon Medical System: Strategies and Development
Table 80 : Caption Health: Product Portfolio
Table 81 : Caption Health: Strategies and Developments
Table 82 : DeepMind: Company Financials, 2020-2019
Table 83 : DeepMind: Product Portfolio
Table 84 : Digital Diagnostics: Product Portfolio
Table 85 : Digital Diagnostics: Strategies and Developments
Table 86 : Enlitic Inc.: Product Portfolio
Table 87 : Fujifilm Holding Corp.: Company Financials, 2019 and 2020
Table 88 : Fujifilm Holding Corp.: Product Portfolio
Table 89 : Fujifilm Holding Corp.: Strategies and Developments
Table 90 : GE: Financial Performance, 2019 and 2020
Table 91 : GE Healthcare: Product Portfolio
Table 92 : GE Healthcare: Strategies and Developments
Table 93 : Heuron Co., Ltd.: Product Portfolio
Table 94 : Heuron Co., Ltd.: Strategies and Developments
Table 95 : Imagen: Product Portfolio
Table 96 : IBM Corp.: Company Financials, 2019 and 2020
Table 97 : IBM Corp.: Product Portfolio
Table 98 : IBM Corp.: Strategies and Developments
Table 99 : iCarbonX: Product Portfolio
Table 100 : Intel Corp.: Product Portfolio in AI Diagnostics
Table 101 : Intel Corp.: Company Financials, 2019 and 2020
Table 102 : Medtronic Plc: Financials, 2019 and 2020
Table 103 : Medtronic Plc: Product Portfolio
Table 104 : Medtronic Plc: Strategies and Developments
Table 105 : Microsoft Corp.: Financials, 2019 and 2020
Table 106 : Microsoft Corp.: Product Portfolio
Table 107 : Microsoft Corp.: Strategies and Developments
Table 108 : Nano-X AI: Product Portfolio
Table 109 : Nano-X AI: Strategies and Developments
Table 110 : Nano-X AI: MSaaS Agreements in 2020
Table 111 : Nvidia: Company Financials, 2019 and 2020
Table 112 : Nvidia: Product Portfolio
Table 113 : NVIDIA: Strategies and Developments
Table 114 : Phillips Healthcare: Financials, 2019 and 2020
Table 115 : Philips Healthcare: Product Portfolio in AI in Diagnostics
Table 116 : Phillips Healthcare: Strategies and Developments
Table 117 : Qure.ai: Product Portfolio
Table 118 : Qure.ai: Strategic Developments
Table 119 : F. Hoffmann-La Roche Ltd.: Financials, 2019 and 2020
Table 120 : F. Hoffmann-La Roche Ltd.: Revenue, by Diagnostic Segment, 2019 and 2020
Table 121 : F. Hoffmann-La Roche Ltd.: Product Portfolio in AI Diagnostics
Table 122 : F. Hoffmann-La Roche Ltd.: Recent Developments
Table 123 : Samsung Electronics Inc.: Product Portfolio
Table 124 : Samsung Electronics Inc.: Strategic Developments
Table 125 : Siemens Healthcare GmbH: Product Segments
Table 126 : Siemens Healthcare GmbH: AI Diagnostics Products
Table 127 : Siemens Healthcare GmbH: Financials, 2019 and 2020
Table 128 : Subtle Medical, Inc.: Product Portfolio
Table 129 : Subtle Medical, Inc.: Strategies and Developments
Table 130 : Synapsica: Product Portfolio
Table 131 : Synapsica: Strategies and Developments
Table 132 : Xilinx, Inc.: Company Financials, 2019 and 2020
Table 133 : Xilinx, Inc.: Product Portfolio
Table 134 : Xilinx, Inc.: Strategies and Developments
List of Figures
Summary Figure A : Global Market for AI Medical Diagnostics, by Region, 2019-2026
Summary Figure B : Global Market Shares of AI Medical Diagnostics, by Region, 2020
Figure 1 : Snapshot of the Global Market for AI Medical Diagnostics
Figure 2 : Global Market for Artificial Intelligence in Medical Diagnostics: Industry Process Flow
Figure 3 : FDA-Approved AI Radiology and Other Imaging Medical Products in the U.S., by Modality, 2018-2021
Figure 4 : FDA-Approved AI Radiology and Other Imaging Medical Products in the U.S., by Medical Specialty, 2018-2021
Figure 5 : FDA-Approved AI Algorithms for Medical Diagnostics in the U.S., 1995-2021
Figure 6 : Shares of FDA-Approved AI Algorithms for Medical Diagnostics in the U.S., by Company, 2018-2021
Figure 7 : FDA-Approved AI Algorithms in the U.S., by Medical Specialty, 2018-2021
Figure 8 : Global Funding in Health-Tech Companies, 2010-2019
Figure 9 : Global Projections for Three Chronic Diseases, 2005-2030
Figure 10 : Global Market for AI Medical Diagnostics, by Component, 2019-2026
Figure 11 : Global Market Shares of AI Medical Diagnostics, by Component, 2020
Figure 12 : Global Market for AI Software in Medical Diagnostics, 2019-2026
Figure 13 : Global Market for AI Software in Medical Diagnostics, by Region, 2019-2026
Figure 14 : Global Market for AI Services in Medical Diagnostics, 2019-2026
Figure 15 : Global Market for AI Services in Medical Diagnostics, by Region, 2019-2026
Figure 16 : Global Market for AI Hardware in Medical Diagnostics, 2019-2026
Figure 17 : Global Market for AI Hardware in Medical Diagnostics, by Region, 2019-2026
Figure 18 : Global Market for AI Medical Diagnostics, by Medical Specialty Application Area, 2019-2026
Figure 19 : Global Market Shares of AI Medical Diagnostics, by Medical Specialty Application Area, 2020
Figure 20 : Global Deaths from Cancer, 2015 and 2030
Figure 21 : Global Market for AI Medical Diagnostics in Oncology, 2019-2026
Figure 22 : Global Market for AI Medical Diagnostics in Oncology, by Region, 2019-2026
Figure 23 : Global Deaths from CVD, 2015 and 2030
Figure 24 : Global Market for AI Medical Diagnostics in Cardiology, 2019-2026
Figure 25 : Global Market for AI Medical Diagnostics in Cardiology, by Region, 2019-2026
Figure 26 : Global Market for AI Medical Diagnostics in Neurology, 2019-2026
Figure 27 : Global Market for AI Medical Diagnostics in Neurology, by Region, 2019-2026
Figure 28 : Global Percentage Distribution of Population Aged Above 65, by Region, 2015 and 2050
Figure 29 : Global Market for AI Medical Diagnostics in Orthopedics, 2019-2026
Figure 30 : Global Market for AI Medical Diagnostics in Orthopedics, by Region, 2019-2026
Figure 31 : Global Market for AI Medical Diagnostics in Other Disease Treatments, 2019-2026
Figure 32 : Global Market for AI Medical Diagnostics in Other Disease Treatments, by Region, 2019-2026
Figure 33 : Global Market for AI Medical Diagnostics, by End User, 2019-2026
Figure 34 : Global Market Shares of AI Medical Diagnostics, by End User, 2020
Figure 35 : Number of Hospitals in the U.S., by Type, 2020
Figure 36 : Global Market for AI in Hospitals and Clinics, 2019-2026
Figure 37 : Global Market for AI in Hospital and Clinics, by Region, 2019-2026
Figure 38 : Global Market for AI Medical Diagnostics in Diagnostic Imaging Centers and Diagnostic Laboratories, 2019-2026
Figure 39 : Global Market for AI Medical Diagnostics in Diagnostic Imaging Centers and Diagnostic Laboratories, by Region, 2019-2026
Figure 40 : Global Market for AI Medical Diagnostics, by Modality, 2020
Figure 41 : Global Market Shares of AI Medical Diagnostics, by Modality, 2020
Figure 42 : Global Market for AI-Based MRI Scans, 2019-2026
Figure 43 : Global Market for AI-Based MRI Scans, by Region, 2019-2026
Figure 44 : Global Market for AI-Based CT Scans, 2019-2026
Figure 45 : Global Market for AI-Based CT Scans, by Region, 2019-2026
Figure 46 : Global Market for AI-Based Ultrasound, 2019-2026
Figure 47 : Global Market for AI-Based Ultrasound, by Region, 2019-2026
Figure 48 : Global Market for AI-Based X-Rays, 2019-2026
Figure 49 : Global Market for AI-Based X-Rays, by Region, 2019-2026
Figure 50 : Annual Revenues in the Endoscopy Devices Market, 2015-2024
Figure 51 : Global Market for AI-Based Other Imaging Techniques, 2019-2026
Figure 52 : Global Market for AI-Based Other Imaging Techniques, by Region, 2019-2026
Figure 53 : Global Market for AI Medical Diagnostics, by Region, 2019-2026
Figure 54 : Global Market Shares of AI Medical Diagnostics, by Region, 2020
Figure 55 : North American Market Shares of AI Medical Diagnostics, by Country, 2020
Figure 56 : U.S. Market for AI Medical Diagnostics, 2019-2026
Figure 57 : Canadian Market for AI Medical Diagnostics, 2019-2026
Figure 58 : Rising Geriatric Population in Germany, 2000-2030
Figure 59 : German Market for AI Medical Diagnostics, 2019-2026
Figure 60 : United Kingdom Market for AI Medical Diagnostics, 2019-2026
Figure 61 : French Market for AI Medical Diagnostics, 2019-2026
Figure 62 : Italian Market for AI Medical Diagnostics, 2019-2026
Figure 63 : Spanish Market for AI Medical Diagnostics, 2019-2026
Figure 64 : Rest of the European Market for AI Medical Diagnostics, 2019-2026
Figure 65 : Allocation of Diagnosed Infectious Diseases in Selected Countries, by Gender, as of 2019
Figure 66 : Chinese Market for AI Medical Diagnostics, 2019-2026
Figure 67 : Japanese Market for AI Medical Diagnostics, 2019-2026
Figure 68 : Indian Market for AI Medical Diagnostics, 2019-2026
Figure 69 : Rest of Asia-Pacific Market for AI Medical Diagnostics, 2019-2026
Figure 70 : Rest of the World Market for AI Medical Diagnostics, 2019-2026
Figure 71 : Patents Granted to Siemens Healthcare GmbH, 2019-2021
Figure 72 : Share of Patents Granted to Siemens Healthcare GmbH, by Geography, 2019-2021
Figure 73 : Patents Granted to General Electric Co., 2019-2021
Figure 74 : Patents Granted to Other Major Players, 2019-2021
Figure 75 : Share of Patents Granted on AI Medical Diagnostics, by Geography, 2019-2021
Figure 76 : Share of Start-ups Founded in the AI Medical Diagnostics Industry, by Region, 2020-2021
Figure 77 : Key Strategies Followed by Companies, by Type of Strategy, 2018-2021
Figure 78 : Key Strategies Followed by Companies, by Type of Strategy, 2018-2021
Figure 79 : Number of Strategic Actions Followed, by Company, 2018-2021
Figure 80 : Canon Medical: Revenue Share, by Region, 2020
Figure 81 : GE: Revenue Share, by Business Segment, 2020
Figure 82 : GE Healthcare: Revenue Share, by Region, 2020
Figure 83 : IBM Corp.: Revenue Share, by Business Segment in AI Diagnostics, 2020
Figure 84 : Intel Corp.: Revenue Share, by Country, 2020
Figure 85 : Microsoft Corp.: Revenue Share, by Geography, 2020
Figure 86 : Phillips Healthcare: Revenue Share, by Geography, 2020
Figure 87 : F. Hoffmann-La Roche Ltd.: Revenue Share, by Segment, 2019
Figure 88 : F. Hoffmann-La Roche Ltd.: Revenue Share, by Geography, 2019
Figure 89 : Siemens Healthcare GmbH: Revenue Share, by Business Segment, 2020
Figure 90 : Siemens Healthcare GmbH: Revenue Share, by Region, 2019
Figure 91 : Xilinx, Inc.: Revenue Share, by Region, 2020